ImmunologybioRxivPreprint
Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
Nathan Singh, Olga Shestova, Pranali Ravikumar…·Marco Ruella
This study identifies impaired death receptor signaling as a driver of resistance to CAR T cell therapy in B-cell leukemia by showing its role in tumor survival and T cell dysfunction.